
International Journal of Nanomedicine, Год журнала: 2025, Номер Volume 20, С. 6043 - 6057
Опубликована: Май 1, 2025
Phototherapy have gained significant traction in the treatment of tumors. However, successful implementation these therapies relies on photosensitizers with superior properties and precise guidance mechanisms. In this study, we introduce an innovative method for surface modification titanium dioxide (TiO2) nanoparticles through HRP-catalyzed covalent incorporation Mn(II) chelate (Mn-Dopa) dopamine. This extends TiO2 nanoparticels' light absorption from ultraviolet to near-infrared (NIR) range, endowing MRI-guided phototherapy capabilities. The resulting nanotheranostics system, TiO2@PDA-MnDopa, demonstrated over 5-fold enhanced relaxivity compared monomeric MnDopa exhibited synergistic effects upon 808 nm laser excitation, a photothermal conversion efficiency 15.91%. vitro vivo pharmacodynamics studies showed that TiO2@PDA-MnDopa good safety HSC3 cell line corresponding tumor-bearing mice, while effectively inhibiting tumor growth under excitation. multifunctional nanotheranostic, integrating high PTT/PDT MR imaging-guided phototherapy, holds great potential applications early diagnosis, noninvasive treatment, prognostic evaluation oral squamous carcinoma.
Язык: Английский